SCHEMBL8947218

SCHEMBL8947218

COC(=O)Cn1nnnc1-c1ccc(SC)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 2/20 0.48
TRPV1 Q8NER1 1/20 0.46
HSD11B1 P28845 2/20 0.43
CYP1A2 P05177 1/20 0.41
GAA P10253 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947317 0.90 ALDH1A1 (0.57) ALDH1A1HPGDMAPK1TRPV1HSD11B1
SCHEMBL8947240 0.86 ALDH1A1 (0.54) ALDH1A1HPGDMAPK1TRPV1HSD11B1
SCHEMBL8947285 0.85 ALDH1A1 (0.68) MAPTALDH1A1HPGDMAPK1HSD11B1
SCHEMBL8947311 0.84 ALDH1A1 (0.57) MAPTALDH1A1HPGDMAPK1TRPV1
SCHEMBL8947278 0.84 ALDH1A1 (0.70) ALDH1A1HPGDMAPK1TRPV1HSD11B1
SCHEMBL8947140 0.84 HSD11B1 (0.59) ALDH1A1HPGDTRPV1HSD11B1SMN1; SMN2
SCHEMBL8947149 0.84 ALDH1A1 (0.51) ALDH1A1HPGDMAPK1TRPV1HSD11B1
SCHEMBL8947310 0.84 TRPV1 (0.63) MAPTALDH1A1HPGDTRPV1HSD11B1
SCHEMBL5966689 0.83 TRPV1 (0.59) MAPTALDH1A1HPGDTRPV1HSD11B1
SCHEMBL8947152 0.83 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1TRPV1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35281-E ANTIDIABETIC AGENTS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
EP-0388967-B1 Aldose reductase inhibitor WAKAMOTO PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5055481-A Alleviate diabetic complications WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-10-08 US disclosed
EP-0388967-A1 Aldose reductase inhibitor Wakamoto Pharmaceutical Co., Ltd. (JP) 1990-09-26 EP disclosed